Revenue (Tables)

9 Months Ended

Sep. 30, 2022

Revenue from Contract with Customer [Abstract]

Summary of Revenue

Revenue consist of the following:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2022		2021		2022		2021
Prescription transactions revenue	$	131,216	$	155,652	$	421,126	$	434,570
Subscription revenue		26,450		16,226		71,545		42,549
Pharma manufacturer solutions revenue (1)		24,499		18,548		74,519		41,060
Other revenue		5,153		4,676		15,255		13,989
Total revenue	$	187,318	$	195,102	$	582,445	$	532,168

(1)Represents revenue from pharma manufacturers and other customers primarily for advertising, including integrating onto our platform their affordability solutions to our consumers. Pharma manufacturer solutions revenue is disclosed separately from other revenue beginning in the first quarter of 2022. Prior period amounts have been recast to conform with the current period presentation.